← Leaderboards
Deming Sun
Doheny Eye Institute
$9,428,559
Attributed
$9,428,559
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,235,601 · 5
By mechanism
R01$9,428,559 · 4
P30$807,042 · 1
Top collaborators
No co-investigators on record.
Most similar at Doheny Eye Institute
Same institution · by research overlap
- Narsing A Rao$6,200,210
- Melvin Douglas Trousdale$2,971,009
Others in their field
Top investigators on “Uveitis”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Janet T. Holbrook · Johns Hopkins University$46,477,725
- Raymond Kraker · Jaeb Center For Health Research, Inc.$27,627,512
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- James T Rosenbaum · Oregon Health And Science University$15,828,860
- Nisha Acharya · University Of California, San Francisco$11,276,781
Research focus
UveitisAutoimmune DiseasesT-LymphocyteAntigensAutoreactive T CellT-Cell ActivationCellsResponseAdoptive TransferAutoimmune UveitisAutoimmune ProcessBasePathogenesisInflammatoryImmunizationImmune ResponseLaboratoriesImmunotherapyVisionPreventGenerationsExperimental ModelsResearch PersonnelCell Communication
Grant awards (28)
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$471,955
R01 · FY2023 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$457,796
R01 · FY2022 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$457,796
R01 · FY2021 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$471,955
R01 · FY2020 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$431,612
R01 · FY2018 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$431,612
R01 · FY2017 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$431,612
R01 · FY2016 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$431,612
R01 · FY2015 · EY · contact PI
Regulation by Gammadelta T Cells of Autoimmune Uveitis (EAU)$234,612
R01 · FY2015 · EY · contact PI
Regulation by Gammadelta T Cells of Autoimmune Uveitis (EAU)$472,751
R01 · FY2014 · EY · contact PI
Regulation by Gammadelta T Cells of Autoimmune Uveitis (EAU)$458,279
R01 · FY2013 · EY · contact PI
Core Grant for Vision Research$190,422
P30 · FY2013 · EY · contact PI
Core Grant for Vision Research$616,620
P30 · FY2012 · EY · contact PI
Regulation by Gammadelta T Cells of Autoimmune Uveitis (EAU)$482,399
R01 · FY2012 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$387,288
R01 · FY2011 · EY · contact PI
Progression of Uveitis and CD8 uveitogenic T cells$296,335
R01 · FY2011 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$403,425
R01 · FY2010 · EY · contact PI
Progression of Uveitis and CD8 uveitogenic T cells$308,682
R01 · FY2010 · EY · contact PI
Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU)$376,000
R01 · FY2009 · EY · contact PI
Progression of Uveitis and CD8 uveitogenic T cells$311,800
R01 · FY2009 · EY · contact PI
Progression of Uveitis and CD8 uveitogenic T cells$305,564
R01 · FY2008 · EY · contact PI
Progression of Uveitis and CD8 uveitogenic T cells$296,000
R01 · FY2007 · EY · contact PI
Characterization of uveitogenic T cells$147,221
R01 · FY2007 · EY · contact PI
Characterization of uveitogenic T cells$138,262
R01 · FY2007 · EY · contact PI
Characterization of uveitogenic T cells$287,091
R01 · FY2006 · EY · contact PI
Characterization of uveitogenic T cells$294,000
R01 · FY2005 · EY
Characterization of uveitogenic T cells$294,000
R01 · FY2004 · EY
Characterization of uveitogenic T cells$348,900
R01 · FY2003 · EY